Manufacturer record
Sresan Pharmaceutical Manufacturer No. 787. Bangalore Highways: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Sresan Pharmaceutical Manufacturer No. 787. Bangalore Highways (Karnataka) was declared Not of Standard Quality in June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: SR-14, Fungal Diastase (Estimated in terms of amylase activity) Pepsin (Estimated in terms ofvolume of undissolved egg albumin) (exp Apr 2027). SDT&RL, Bhubaneswar (state lab) found it not of standard quality: Alpha amylase activity and Pepsin content. Listed in the June 2026 alert.
Records by type
1 record linked to Sresan Pharmaceutical Manufacturer No. 787. Bangalore Highways in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Fungal Diastase (Estimated in terms of amylase activity) Pepsin (Estimated in terms ofvolume of undissolved egg albumin) | Batch SR-14Mfg May 2025 · Exp Apr 2027 | Alpha amylase activity and Pepsin contentOther | SDT&RL, BhubaneswarState lab | Jun 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.